Aurora Cannabis (ACB) will benefit as the market falls
Aurora Cannabis Inc (ACB) currently trades at $0.85 and has fallen by 6.15% today. Aurora Cannabis will ultimately benefit from global cannabis sales, but the coronavirus outbreak could push this benefit into 2021. Aurora flounders back close to $1, the negative atmosphere surrounding the stock shouldn’t completely overshadow the opportunities for the Canadian cannabis company in 2020 and beyond.
Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating because the company has substantial catalysts in 2020 including additional retail stores in Canada, the rollout of Cannabis 2.0 products and global expansion including the U.S. CBD market. The high forecast for Aurora Cannabis Inc is $3.00 and the low is $0.72. Notably, the company’s market cap is $958.09 million with a 52 week high of $9.37 and a 52 week low of $0.83.